2026. GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE. International journal of medical sciences. 6, 4 (Apr. 2026), 849–855. DOI:https://doi.org/10.55640/.